Morgan Stanley Tenaya Therapeutics, Inc. Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 167,089 shares of TNYA stock, worth $227,241. This represents 0.0% of its overall portfolio holdings.

Number of Shares

167,089

Previous 115,879 44.19%

Holding current value

$227,241

Previous $70,000 264.29%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$0.58 - $1.66 $29,701 - $85,008	51,210 Added 44.19%	167,089 $255,000
Q2 2025 Aug 15, 2025	SELL	$0.39 - $0.69 $77,481 - $137,082	-198,670 Reduced 63.16%	115,879 $70,000
Q1 2025 May 15, 2025	SELL	$0.44 - $1.52 $516,453 - $1.78 Million	-1,173,757 Reduced 78.87%	314,549 $179,000
Q4 2024 Feb 14, 2025	BUY	$1.23 - $3.78 $1.45 Million - $4.44 Million	1,175,315 Added 375.51%	1,488,306 $2.13 Million
Q3 2024 May 14, 2025	BUY	$1.93 - $3.99 $261,067 - $539,719	135,268 Added 76.11%	312,991 $604,000

Q3 2024 Nov 14, 2024	BUY	$1.93 - $3.99 $261,067 - $539,719	135,268 Added 76.11%	312,991 $604,000
Q2 2024 May 14, 2025	SELL	$2.72 - $4.99 $3.56 Million - $6.54 Million	-1,310,583 Reduced 88.06%	177,723 $550,000
Q2 2024 Oct 17, 2024	SELL	$2.72 - $4.99 $375,811 - $689,448	-138,166 Reduced 43.74%	177,723 $550,000
Q2 2024 Aug 14, 2024	SELL	$2.72 - $4.99 $375,811 - $689,448	-138,166 Reduced 43.74%	177,723 $550,000
Q1 2024 Oct 17, 2024	BUY	$2.88 - $6.8 $397,918 - $939,528	138,166 Added 77.74%	315,889 $1.65 Million
Q1 2024 Aug 16, 2024	BUY	$2.88 - $6.8 $241,583 - $570,404	83,883 Added 36.16%	315,889 $1.65 Million
Q1 2024 May 15, 2024	BUY	$2.88 - $6.8 $241,583 - $570,404	83,883 Added 36.16%	315,889 $1.65 Million
Q4 2023 Aug 16, 2024	BUY	$1.73 - $3.39 $93,909 - $184,019	54,283 Added 30.54%	232,006 $751,000
Q4 2023 Feb 13, 2024	BUY	$1.73 - $3.39 $256,010 - $501,662	147,983 Added 176.12%	232,006 $751,000
Q3 2023 Nov 15, 2023	SELL	$2.55 - $5.65 $72,277 - $160,143	-28,344 Reduced 25.22%	84,023 $214,000
Q2 2023 Aug 14, 2023	BUY	$2.64 - $7.64 $84,342 - $244,082	31,948 Added 39.73%	112,367 $659,000
Q1 2023 May 15, 2023	BUY	$1.92 - $3.59 $100,913 - $188,686	52,559 Added 188.65%	80,419 $229,000
Q4 2022 Feb 14, 2023	BUY	$1.68 - $3.19 $22,849 - $43,387	13,601 Added 95.39%	27,860 $55,000
Q3 2022 Nov 14, 2022	BUY	$2.9 - $5.88 $3,358 - $6,809	1,158 Added 8.84%	14,259 $41,000
Q2 2022 Oct 27, 2022	BUY	$5.01 - $14.12 $7,835 - $22,083	1,564 Added 13.56%	13,101 $75,000
Q2 2022 Aug 15, 2022	BUY	$5.01 - $14.12 $7,835 - $22,083	1,564 Added 13.56%	13,101 $75,000
Q1 2022 Oct 27, 2022	SELL	$9.41 - $19.3 $14,717 - $30,185	-1,564 Reduced 11.94%	11,537 $135,000
Q1 2022 May 13, 2022	SELL	$9.41 - $19.3 $175,600 - $360,157	-18,661 Reduced 61.8%	11,537 $135,000
Q4 2021 Feb 14, 2022	BUY	$18.41 - $29.58 $499,500 - $802,564	27,132 Added 884.93%	30,198 $572,000
Q3 2021 Nov 15, 2021	BUY	$15.35 - $26.66 $47,063 - $81,739	3,066 New	3,066 $63,000

Others Institutions Holding TNYA

# of Institutions

Shares Held

38.2M

Call Options Held

313K

Put Options Held

61.1K

View Full List

About Tenaya Therapeutics, Inc.

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $56.3M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

More about TNYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account